| | | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
|---|
| Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
| | | FI | | | Gastrografin | 100 ml | 15.41 | 33.20 | 10% | | Lösung zum Einnehmen / Rektallösung: 2 Wirkstoffe | Bayer (Schweiz) AG | B / SL / SO | FB | | G |  |
| L | | FI | | | Gastrografin | 10 x 100 ml | 154.10 | 184.00 | 10% | | Lösung zum Einnehmen / Rektallösung: 2 Wirkstoffe | Bayer (Schweiz) AG | B / SL / SO | FB | | G | |
|
| | | FI | | | Xenetix 300 mg | 50 ml | 23.45 | 41.90 | 10% | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B / SL | FB | | G | |
| | | FI | | | Xenetix 300 mg | 100 ml | 45.38 | 65.75 | 10% | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B / SL | FB | | G | |
| | | FI | | | Xenetix 300 mg | 200 ml | 90.76 | 115.10 | 10% | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B / SL | FB | | G | |
| | | FI | | | Xenetix 300 mg | 500 ml | 226.90 | 263.20 | 10% | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Xenetix 300 mg | 10 x 100 ml | 453.80 | 509.95 | 10% | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Xenetix 300 mg | 10 x 200 ml | 907.60 | 1003.50 | 10% | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Xenetix 300 mg | 10 x 200 ml | 907.60 | 1003.50 | 10% | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Xenetix 300 mg | 10 x 500 ml | 2269.00 | 2484.10 | 10% | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Xenetix 300 mg | 10 x 500 ml | 2269.00 | 2484.10 | 10% | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B / SL | FB | | G | |
| | | FI | | | Xenetix 350 mg | 20 ml | 11.92 | 29.40 | 10% | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B / SL | FB | | G | |
| | | FI | | | Xenetix 350 mg | 50 ml | 25.69 | 44.35 | 10% | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B / SL | FB | | G | |
| | | FI | | | Xenetix 350 mg | 100 ml | 49.61 | 70.35 | 10% | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B / SL | FB | | G | |
| | | FI | | | Xenetix 350 mg | 200 ml | 99.23 | 124.35 | 10% | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B / SL | FB | | G | |
| | | FI | | | Xenetix 350 mg | 500 ml | 248.07 | 286.20 | 10% | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Xenetix 350 mg | 10 x 100 ml | 496.14 | 556.00 | 10% | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Xenetix 350 mg | 10 x 200 ml | 992.29 | 1095.60 | 10% | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Xenetix 350 mg | 10 x 200 ml | 992.29 | 1095.60 | 10% | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Xenetix 350 mg | 10 x 500 ml | 2480.72 | 2714.35 | 10% | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Xenetix 350 mg | 10 x 500 ml | 2480.72 | 2714.35 | 10% | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B / SL | FB | | G | |
| | | FI | | | Xenetix 300 mg | 100 ml | PA | PA | k.A. | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B | FB | | G | |
| | | FI | | | Xenetix 300 mg | 100 ml | PA | PA | k.A. | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B | FB | | G | |
| | | FI | | | Xenetix 300 mg | 200 ml | PA | PA | k.A. | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B | FB | | G | |
| | | FI | | | Xenetix 300 mg | 500 ml | PA | PA | k.A. | | Injektionslösung: Iobitridolum 658.1 mg/ml | Guerbet AG | B | FB | | G | |
| | | FI | | | Xenetix 350 mg | 100 mg | PA | PA | k.A. | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B | FB | | G | |
| | | FI | | | Xenetix 350 mg | 200 mg | PA | PA | k.A. | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B | FB | | G | |
| | | FI | | | Xenetix 350 mg | 500 mg | PA | PA | k.A. | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B | FB | | G | |
| | | FI | | | Xenetix 350 mg | 20 ml | PA | PA | k.A. | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B | FB | | G | |
| | | FI | | | Xenetix 350 mg | 100 ml | PA | PA | k.A. | | Injektionslösung: Iobitridolum 767.8 mg/ml | Guerbet AG | B | FB | | G | |
|
| | | FI | | | Lipiodol Ultra-fluide | Ampulle(n) | PA | PA | k.A. | | Injektionslösung: Iodum 4.8 g | Guerbet AG | B | FB | | G | |
|
| | | FI | | | Micropaque | 500 ml | 5.83 | 15.55 | 10% | | Suspension: Barii Sulfas 100 g | Guerbet AG | B / SL | FB | | G | |
| | | FI | | | Micropaque Scanner | 150 ml | 4.58 | 14.20 | 10% | | Suspension: Barii Sulfas 7.5 g | Guerbet AG | B / SL | FB | | G | |
| | | | | | Microtrast | 800 g | PA | PA | k.A. | | Paste: Barii Sulfas 70 g | Guerbet AG | B | FB | | G | |
|
| | | FI | | | Cyclolux | 10 ml | 27.28 | 46.10 | 10% | | Injektionslösung: Acidum Gadotericum 279.32 mg/ml | b.e.imaging.ag | B / SL / SG | FB | | G | |
| | | FI | | | Cyclolux | 15 ml | 37.07 | 56.75 | 10% | | Injektionslösung: Acidum Gadotericum 279.32 mg/ml | b.e.imaging.ag | B / SL / SG | FB | | G | |
| | | FI | | | Cyclolux | 20 ml | 46.85 | 67.35 | 10% | | Injektionslösung: Acidum Gadotericum 279.32 mg/ml | b.e.imaging.ag | B / SL / SG | FB | | G | |
| L | | FI | | | Cyclolux | 60 ml | 130.97 | 158.20 | 10% | | Injektionslösung: Acidum Gadotericum 279.32 mg/ml | b.e.imaging.ag | B / SL / SG | FB | | G | |
| L | | FI | | | Cyclolux | 100 ml | 218.28 | 253.80 | 10% | | Injektionslösung: Acidum Gadotericum 279.32 mg/ml | b.e.imaging.ag | B / SL / SG | FB | | G | |
| | | FI | | | Dotarem | 10 ml | 41.96 | 61.15 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | | FI | | | Dotarem | 10 ml | 41.96 | 61.15 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | | FI | | | Dotarem | 15 ml | 57.03 | 77.20 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | | FI | | | Dotarem | 15 ml | 57.03 | 77.20 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | | FI | | | Dotarem | 20 ml | 72.07 | 93.25 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | | FI | | | Dotarem | 20 ml | 72.07 | 93.25 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| L | | FI | | | Dotarem | 60 ml | 216.21 | 245.65 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / SL / SO | FB | | G | |
| | | FI | | | Clariscan | 10 ml | 27.28 | 46.10 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | | FI | | | Clariscan | 10 ml | 27.28 | 46.10 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | | FI | | | Clariscan | 15 ml | 37.07 | 56.75 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | | FI | | | Clariscan | 15 ml | 37.07 | 56.75 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | | FI | | | Clariscan | 20 ml | 46.85 | 67.35 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | | FI | | | Clariscan | 20 ml | 46.85 | 67.35 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | | FI | | | Clariscan | 50 ml | 109.14 | 135.80 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | | FI | | | Clariscan | 100 ml | 218.28 | 253.80 | 10% | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B / SL / SG | FB | | G | |
| | | FI | | | Artirem | Durchstechflasche(n) à 20 ml | 43.02 | 63.20 | 10% | | Injektionslösung: Acidum Gadotericum 1.397 mg/ml | Guerbet AG | B / SL | FB | | G | |
| | | FI | | | Clariscan | 50 ml | PA | PA | k.A. | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B | FB | | G | |
| | | FI | | | Clariscan | 60 ml | PA | PA | k.A. | | Injektionslösung: Acidum Gadotericum 279.3 mg/ml | GE Healthcare AG | B | FB | | G | |
|
| | | FI | | | ProHance 0.5 mmol/ml | Flasche(n) à 10 ml | 43.49 | 63.70 | 10% | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | Flasche(n) à 15 ml | 61.39 | 83.20 | 10% | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | Flasche(n) à 20 ml | 79.46 | 102.85 | 10% | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | Flasche(n) à 50 ml | 201.94 | 236.05 | 10% | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 10 ml | 43.49 | 63.70 | 10% | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 17 ml | 69.44 | 91.95 | 10% | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / SL | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | Flasche(n) à 5 ml | 27.63 | 48.10 | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 5 1 Flasche(n) à 5 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 10 1 Flasche(n) à 5 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 5 1 Flasche(n) à 10 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 5 1 Flasche(n) à 15 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 20 1 Flasche(n) à 5 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 10 1 Flasche(n) à 10 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 5 1 Flasche(n) à 20 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 10 1 Flasche(n) à 15 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 20 1 Flasche(n) à 10 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 10 1 Flasche(n) à 20 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 20 1 Flasche(n) à 15 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 20 1 Flasche(n) à 20 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 10 1 Flasche(n) à 50 ml | PA | PA | k.A. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 15 ml | PA | PA | k.A. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 5 x 10 ml | PA | PA | k.A. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 5 x 15 ml | PA | PA | k.A. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | FI | | | ProHance 0.5 mmol/ml | 5 x 17 ml | PA | PA | k.A. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
|
| | | FI | | | Gadovist 1,0 | 2 ml | 13.25 | 30.85 | 10% | | Injektionslösung: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | | FI | | | Gadovist 1,0 | Spritze(n) à 5 ml | 45.62 | 66.05 | 10% | | Injektionslösung: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | | FI | | | Gadovist 1,0 | Spritze(n) à 7.5 ml | 68.43 | 90.85 | 10% | | Injektionslösung: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | | FI | | | Gadovist 1,0 | Spritze(n) à 10 ml | 77.55 | 100.75 | 10% | | Injektionslösung: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | | FI | | | Gadovist 1,0 | Spritze(n) à 15 ml | 124.02 | 151.30 | 10% | | Injektionslösung: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | | FI | | | Gadovist 1,0 | Flasche(n) à 30 ml | 198.79 | 232.60 | 10% | | Injektionslösung: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| L | | FI | | | Gadovist 1,0 | Flasche(n) à 65 ml | 410.46 | 462.80 | 10% | | Injektionslösung: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | | FI | | | Gadovist 1,0 | Spritze(n) à 5 ml | PA | PA | k.A. | | Injektionslösung: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | | FI | | | Gadovist 1,0 | Spritze(n) à 7.5 ml | PA | PA | k.A. | | Injektionslösung: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | | FI | | | Gadovist 1,0 | Spritze(n) à 10 ml | PA | PA | k.A. | | Injektionslösung: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | | FI | | | Gadovist 1,0 | Spritze(n) à 15 ml | PA | PA | k.A. | | Injektionslösung: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
|
| | KFI | FI | | | Primovist 0.25 mmol/ml | Spritze(n) | 158.40 | 188.70 | 10% | | Injektionslösung: Dinatrii Gadoxetas 181.43 mg/ml | Bayer (Schweiz) AG | B / SL | FB | | G | |
| | KFI | FI | | | Primovist 0.25 mmol/ml | | PA | PA | k.A. | | Injektionslösung: Dinatrii Gadoxetas 181.43 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
|
| L | | FI | | | Elucirem 0.5 mmol/ml | 7.5 ml | 62.28 | 84.15 | 10% | | | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Elucirem 0.5 mmol/ml | 7.5 ml | 62.28 | 84.15 | 10% | | | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Elucirem 0.5 mmol/ml | 10 ml | 83.04 | 106.75 | 10% | | | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Elucirem 0.5 mmol/ml | 10 ml | 83.04 | 106.75 | 10% | | | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | | Elucirem 0.5 mmol/ml | 30 ml | 186.85 | 219.65 | 10% | | | Guerbet AG | B / SL | FB | | G | |
| L | | FI | | CM | Vueway | 7.5 ml | 62.28 | 84.15 | 10% | | | Bracco Suisse SA | B / SL | FB | | G | |
| L | | FI | | CM | Vueway | 10 ml | 83.04 | 106.75 | 10% | | | Bracco Suisse SA | B / SL | FB | | G | |
| L | | FI | | CM | Vueway | 15 ml | 107.12 | 132.90 | 10% | | | Bracco Suisse SA | B / SL | FB | | G | |
| | | FI | | | Elucirem 0.5 mmol/ml | 3 ml | PA | PA | k.A. | | | Guerbet AG | B | FB | | G | |
| | | FI | | | Elucirem 0.5 mmol/ml | 15 ml | PA | PA | k.A. | | | Guerbet AG | B | FB | | G | |
| | | FI | | CM | Vueway | 3 ml | PA | PA | k.A. | | | Bracco Suisse SA | B | FB | | G | |
| | | FI | | CM | Vueway | 7.5 ml | PA | PA | k.A. | | | Bracco Suisse SA | B | FB | | G | |
| | | FI | | CM | Vueway | 30 ml | PA | PA | k.A. | | | Bracco Suisse SA | B | FB | | G | |
